Conduit Pharmaceuticals Management
Management criteria checks 0/4
Conduit Pharmaceuticals' CEO is Dave Tapolczay, appointed in Sep 2023, has a tenure of less than a year. total yearly compensation is $1.62M, comprised of 8.6% salary and 91.4% bonuses, including company stock and options. directly owns 2.71% of the company’s shares, worth $380.63K. The average tenure of the management team and the board of directors is 0.3 years and 0.9 years respectively.
Key information
Dave Tapolczay
Chief executive officer
US$1.6m
Total compensation
| CEO salary percentage | 8.6% |
| CEO tenure | less than a year |
| CEO ownership | 2.7% |
| Management average tenure | less than a year |
| Board average tenure | less than a year |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$2m |
| Dec 31 2023 | US$2m | US$140k | -US$535k |
Compensation vs Market: Dave's total compensation ($USD1.62M) is above average for companies of similar size in the US market ($USD690.60K).
Compensation vs Earnings: Insufficient data to compare Dave's compensation with company performance.
CEO
Dave Tapolczay (65 yo)
less than a year
Tenure
US$1,623,038
Compensation
Dr. David Joszef Tapolczay, also known as Dave, serves as the Chief Executive Officer of the Medical Research Council Technology Group (MRCT). He serves as Chief Executive Officer and Director at Conduit P...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | US$1.62m | 2.71% $ 380.6k | |
| Interim CFO & Director | less than a year | US$1.44m | 0.050% $ 7.1k | |
| Chief Scientific Officer | less than a year | no data | no data | |
| Senior VP of Investor Relations | less than a year | no data | no data |
0.3yrs
Average Tenure
49yo
Average Age
Experienced Management: CDT's management team is not considered experienced ( 0.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | US$1.62m | 2.71% $ 380.6k | |
| Interim CFO & Director | less than a year | US$1.44m | 0.050% $ 7.1k | |
| Director | less than a year | US$842.08k | 0.090% $ 12.7k | |
| Independent Director | less than a year | US$267.43k | no data | |
| Independent Chairman of the Board | less than a year | US$275.31k | 3.41% $ 478.9k | |
| Independent Director | no data | US$268.93k | 0.071% $ 9.9k |
0.9yrs
Average Tenure
57yo
Average Age
Experienced Board: CDT's board of directors are not considered experienced ( 0.9 years average tenure), which suggests a new board.